Historique
Auteur F. SCHIFANO
Documents disponibles écrits par cet auteur (59)
Ajouter le résultat à votre sélection Affiner la recherche
J. M. CORKERY ; S. ELLIOTT ; F. SCHIFANO ; O. CORAZZA ; A. H. GHODSE | 2012
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.39, n°2, 3 December 2012) Article : Périodique2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) are psychoactive substances, sold primarily over the Internet and in 'head' shops as 'legal highs', 'rese[...]
C. T. GALLAGHER ; S. ASSI ; J. L. STAIR ; S. FERGUS ; O. CORAZZA ; J. M. CORKERY ; F. SCHIFANO | 2012
Dans Human Psychopharmacology: Clinical and Experimental (Vol.27, n°2, March 2012) Article : PériodiqueOBJECTIVES: The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the[...]
FRANÇAIS : Description d'un cas de dépendance à la trimébutine, antispasmodique musculotrope.
L'ecstasy devient de plus en plus populaire en Italie du Nord. Le MDMA a des propriétés hallucinogènes et excitantes. L'usage d'ecstasy semble provoquer aussi anxiété, insomnie, crises de paranoïa, confusion. Deux cas sont présentés ici (psychop[...]
J. M. CORKERY ; H. CLARIDGE ; C. GOODAIR ; F. SCHIFANO | 2017
Dans Journal of Psychopharmacology (Vol.31, n°8, August 2017) Article : PériodiqueCocaine-related deaths have increased since the early 1990s in Europe, including the UK. Being multi-factorial, they are difficult to define, detect and record. The European Monitoring Centre for Drugs and Drug Addiction commissioned research to[...]
RATIONALE: The issue of ecstasy-related fatalities has extensively attracted the attention of both the media and the general public, but less so of the scientific literature. OBJECTIVES: The aim of the present review is to focus on the epidemiol[...]
F. SCHIFANO ; J. CORKERY ; E. GILVARRY ; P. DELUCA ; A. OYEFESO ; A. H. GHODSE | 2005
Dans Human Psychopharmacology: Clinical and Experimental (Vol.20, n°5, July 2005) Article : PériodiqueBuprenorphine safety in overdose has been debated recently, but no mortality data related to this compound from the UK have been published. To gather together all of the buprenorphine mortality figures, a number of different sources have been ch[...]
F. SCHIFANO ; J. CORKERY | 2008
Dans Journal of Psychopharmacology (Vol.22, n°1, 2008) Article : PériodiqueA recent trend of escalating use of cocaine/crack cocaine was observed in the UK. The number of mentions on death certificates; last year use of cocaine; treatment demand, number of drug offenders, seizures, prices and average purity levels were[...]
B. LOI ; J. M. CORKERY ; H. CLARIDGE ; C. GOODAIR ; S. CHIAPPINI ; C. GIMENO CLEMENTE ; F. SCHIFANO | 2015
Dans Human Psychopharmacology: Clinical and Experimental (Vol.30, n°4, July 2015) Article : PériodiqueObjective: Mephedrone is a stimulant drug chemically related to amphetamine, with effects similar to those of amphetamine and cocaine. This study aims to analyse fatalities following ingestion of mephedrone in the UK amongst 16- to 24-year-olds [...]
O. CORAZZA ; F. SCHIFANO ; M. FARRE ; P. DELUCA ; Z. DAVEY ; C. DRUMMOND ; M. TORRENS ; Z. DEMETROVICS ; L. DI FURIA ; L. H. FLESLAND ; B. MERVO ; J. MOSKALEWICZ ; A. PISARSKA ; H. SHAPIRO ; H. SIEMANN ; A. SKUTLE ; C. PEZZOLESI ; P. VAN DER KREEFT ; N. SCHERBAUM | 2011
PériodiqueBased on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-[...]
V. REISSNER ; A. KOKKEVI ; F. SCHIFANO ; R. ROOM ; J. STORBJÖRK ; R. STOHLER ; L. DiFURIA ; J. REHM ; M. GEYER ; F. HÖLSCHER ; N. SCHERBAUM | 2012
Dans European Psychiatry (Vol.27, n°6, August 2012) Article : PériodiqueObjectives: This comparative study investigated consumption patterns, comorbidity and treatment utilization of opioid addicts in six European cities (Athens, Essen, London, Padua, Stockholm, Zurich). Subjects and methods: Data were collected b[...]
Notifications of 1,539drug-related deaths occurring in 2007 were received by the Programme. A total of 107 coroners from 115 jurisdictions in England & Wales, as well as from Northern Ireland, the Channel Islands and Isle of Man, together with o[...]
The National Programme on Substance Abuse Deaths (np-SAD) principal aim is to contribute to the reduction and prevention of drug-related deaths in the UK due to the misuse of drugs, both licit and illicit, by collecting, analysing and disseminat[...]
ENGLISH : This eleventh annual report presents information on drug-related deaths that occurred during 2009 and for which Coronial inquests and similar formal investigations have been completed. The main purpose of the Annual Report from the n[...]
FRANÇAIS : Meow, meow, Benzo Fury, PMA figurent aujourd'hui parmi celles que l'on appelle les nouvelles substances psychoactives (Novel Psychoactive Substances) responsables d'un nombre de décès croissant en Grande Bretagne : 10 décès en 2009 c[...]
